Advancements in the treatment of psoriasis: role of biologic agents. [electronic resource]
Producer: 20041019Description: 318-25 p. digitalISSN:- 1083-4087
- Alefacept
- Antibodies, Monoclonal -- economics
- Antibodies, Monoclonal, Humanized
- Biological Products -- economics
- Cost-Benefit Analysis
- Dermatologic Agents -- economics
- Etanercept
- Humans
- Immunoglobulin G -- economics
- Infliximab
- PUVA Therapy
- Psoriasis -- immunology
- Randomized Controlled Trials as Topic
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Recombinant Fusion Proteins -- economics
- Ultraviolet Rays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.